Skip to main content

Table 2 The general and clinical characteristics of children in different subtypes of SMA

From: New multiplex real-time PCR approach to detect gene mutations for spinal muscular atrophy

 

Type I (%)

(n = 41)

Type II (%)

(n = 29)

Type III (%) (n = 5)

Total (%) (n = 75)

P Value*

Gender*

 Boy

24 (58.54)

19 (65.52)

3 (60)

46 (61.33)

 

 Girl

17 (41.46)

10 (34.48)

2 (40)

29 (38.67)

 

Clinical symptoms*

 Congenital heart disease

3 (7.32)

0

0

3 (4)

0.5137

 Respiratory failure

6 (14.63)

2 (6.90)

0

8 (10.67)

0.7308

 Muscular atrophy

20 (48.78)

13 (44.83)

2 (40)

35 (46.67)

0.9835

 EMG abnormalities

39 (95.12)

28 (96.55)

4 (80)

71 (94.67)

0.4405

Prenatal*

 Ultrasonography abnormalities

0

0

0

0

-

 Decreased fetal movement

3 (7.32)

2 (6.90)

0

5 (6.67)

1.0000

CK value*

 Normal

6 (14.63)

8 (27.59)

2 (40)

16 (21.33)

0.3391

 Elevation

35 (85.37)

21 (72.41)

3 (60)

59 (78.67)

 

Molecular detection

 Homozygous mutation at c.840 C > T in SMN gene

40 (97.56)

26 (89.66)

5 (100)

71 (94.67)

 

 Deletion of NAIP exon4 and 5

6 (14.63)

0

0

6 (8)

 

 Deletion of NAIP exon4

3 (7.32)

0

0

3 (4)

 

 Deletion of GTF2H2 exon10

2 (4.88)

1 (3.45)

0

3 (4)

 
  1. *Fisher’s exact test